BioLife Solutions, Inc.BLFSNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 119 | 76 | 76 |
| Gross Profit | 29 | 47 | 47 |
| Operating Income | -35 | -6 | -23 |
| Net Income | -9 | -140 | -66 |
| EBITDA | -17 | -124 | -45 |
| EPS Diluted | -0.23 | -3.29 | -1.52 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 70 | 19 | 28 |
| Total Current Assets | 126 | 138 | 121 |
| Total Assets | 553 | 450 | 413 |
| Total Current Liabilities | 43 | 45 | 42 |
| Total Liabilities | 76 | 86 | 75 |
| Total Equity | 481 | 364 | 338 |
| Total Debt | 27 | 44 | 34 |
| Net Debt | -43 | 24 | 6 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -5 | -8 | -12 |
| Capital Expenditure | -8 | -10 | -6 |
| Free Cash Flow | -13 | -19 | -19 |
| Stock-Based Comp | 14 | 25 | 32 |
| Net Change in Cash | -21 | -50 | 16 |